Skip to content

Acupuncture in pain patients with Chronic Kidney Disease

Effect of Acupuncture on Chronic Renal pain patients in hemodyalysis: randomized trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
REBEC
Registry ID
RBR-3cpwwt
Enrollment
Unknown
Registered
2020-02-28
Start date
2019-06-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Experimental Group: 47 chronic renal patients will receive ear acupuncture with spherical crystals at points pre-established by the study. Control Group: 47 chronic kidney patients will receive placeb
Other
H02.004
E02.190.044.133

Sponsors

Geórgia Alcantara Alencar Melo
Lead Sponsor
Geórgia Alcantara Alencar Melo
Collaborator

Eligibility

Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: The criteria for inclusion were: age between 30 and 60 years; with over a year of dialysis therapy; that is registered in the clinic through the SUS; with moderate pain assessed from the analog pain scale; with punctuation on the Glasgow scale of 15; with preserved hearing acuity through propaedeutic tests Weber and Rinne Test); and preserved cognitive function assessed by the Mini Mental State Examination (MEEM).

Exclusion criteria

Exclusion criteria: Mental deficiency diagnosed; use of another method of practice complementary alternatives; use of opioids; have a dermatological lesion or absence of limb at the application; and being pregnant. Discontinuity criteria: Participants wish not to continue in research after first session; present any unpleasant reaction associated with the treatment; no agree that needles are inserted at some point; have taken analgesic or relaxing medication muscle in the last 12 hours prior to the session; no participation in two more acupuncture sessions, either for hospitalization, hemodialysis session absence or other reason.

Design outcomes

Primary

MeasureTime frame
It is expected to find pain reduction verified by the visual analogue scale (VAS) and the McGill pain questionnaire, from a measurement of at least 20% in the pre and post intervention measurements.

Secondary

MeasureTime frame
It is expected to find improvement in the disability, verified by the questionnaires of Roland and Morris inability, from a variation of at least 10% in the pre and post intervention measurements.;It is expected to find an improvement in sleep quality, verified by the Pittsburg sleep quality index, from a variation of at least 10% in the pre and post intervention measurements.;It is expected to assess anxiety using the trace-state anxiety questionnaire and to find an improvement of at least 10% in the pre- and post-intervention measurements.;It is expected to assess fatigue using the Piper fatigue scale and to find an improvement of at least 10% in the pre and post intervention measurements.

Countries

Brazil

Contacts

Public ContactGeorgia Melo

Universidade Federal do Ceará

georgiaenf@hotmail.com+5585992390899

Outcome results

None listed

Source: REBEC (via WHO ICTRP)